These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 30858542)
1. Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis. Kajal K; Panda AK; Bhat J; Chakraborty D; Bose S; Bhattacharjee P; Sarkar T; Chatterjee S; Kar SK; Sa G Sci Rep; 2019 Mar; 9(1):4073. PubMed ID: 30858542 [TBL] [Abstract][Full Text] [Related]
2. Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade. Shen K; Ji L; Lu B; Xu C; Gong C; Morahan G; Wang Z Chem Biol Interact; 2014 Jul; 218():99-106. PubMed ID: 24814888 [TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic activity of a new andrographolide derivative in zebrafish and HUVECs. Li J; Peng Y; Li S; Sun Y; Chan JY; Cui G; Wang D; Zhou GC; Lee SM Eur J Pharmacol; 2016 Oct; 789():344-353. PubMed ID: 27471159 [TBL] [Abstract][Full Text] [Related]
4. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055 [TBL] [Abstract][Full Text] [Related]
5. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Bräutigam J; Bischoff I; Schürmann C; Buchmann G; Epah J; Fuchs S; Heiss E; Brandes RP; Fürst R J Mol Cell Cardiol; 2019 Oct; 135():97-108. PubMed ID: 31381906 [TBL] [Abstract][Full Text] [Related]
7. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028 [TBL] [Abstract][Full Text] [Related]
8. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Wang N; Wang ZY; Mo SL; Loo TY; Wang DM; Luo HB; Yang DP; Chen YL; Shen JG; Chen JP Breast Cancer Res Treat; 2012 Aug; 134(3):943-55. PubMed ID: 22350787 [TBL] [Abstract][Full Text] [Related]
9. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling. Ma Q; Chen W; Chen W Tumour Biol; 2016 May; 37(5):6107-16. PubMed ID: 26611645 [TBL] [Abstract][Full Text] [Related]
11. An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway. Huang B; Peng Y; Li J; Li S; Sun Y; Wang D; Yang B; Chan JY; Yu H; Leung GP; Hoi MP; Zhou GC; Lee SM Mol Biosyst; 2017 Feb; 13(3):525-536. PubMed ID: 28098292 [TBL] [Abstract][Full Text] [Related]
12. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo. Cho HD; Lee KW; Won YS; Kim JH; Seo KI J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685 [TBL] [Abstract][Full Text] [Related]
13. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway. Niu G; Sun L; Pei Y; Wang D Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844 [TBL] [Abstract][Full Text] [Related]
14. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways. Li X; Wang X; Ye H; Peng A; Chen L Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678 [TBL] [Abstract][Full Text] [Related]
15. Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. Liang Y; Zhang Y; Wang G; Li Y; Huang W Molecules; 2017 Jan; 22(1):. PubMed ID: 28098802 [TBL] [Abstract][Full Text] [Related]
16. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells. Willis CD; Poluzzi C; Mongiat M; Iozzo RV FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253 [TBL] [Abstract][Full Text] [Related]
17. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337 [TBL] [Abstract][Full Text] [Related]
18. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904 [TBL] [Abstract][Full Text] [Related]
20. A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway. Gong C; Xu C; Ji L; Wang Z Biosci Trends; 2013 Oct; 7(5):230-6. PubMed ID: 24241173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]